Cargando…
Cervical cancer heterogeneity: a constant battle against viruses and drugs
Cervical cancer is the first identified human papillomavirus (HPV) associated cancer and the most promising malignancy to be eliminated. However, the ever-changing virus subtypes and acquired multiple drug resistance continue to induce failure of tumor prevention and treatment. The exploration of ce...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670454/ https://www.ncbi.nlm.nih.gov/pubmed/36397138 http://dx.doi.org/10.1186/s40364-022-00428-7 |